Evidence map›Paper›PMID 25676418›Full record

ArticleLeukemia2015

Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors.

D Zhu, S Bhatt, X Lu, F Guo, H Veelken, D K Hsu, F-T Liu, S Alvarez Cubela, K Kunkalla, F Vega and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. NovelHaematologica · 2018
    Article
  12. Targeting the B cell receptor pathway in non-Hodgkin lymphoma.Expert opinion on investigational drugs · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

D ZhuDivision of Hematology and Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
S Bhatt1] Division of Hematology and Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA [2] Department of Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
X LuDivision of Hematology and Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
F GuoDivision of Hematology and Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
H VeelkenDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
D K HsuDepartment of Dermatology, School of Medicine, University of California-Davis, Sacramento, CA, USA.
F-T Liu1] Department of Dermatology, School of Medicine, University of California-Davis, Sacramento, CA, USA [2] Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC [3] Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.
S Alvarez CubelaDiabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
K KunkallaDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
F VegaDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
J R Chapman-FredricksDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
I S Lossos1] Division of Hematology and Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA [2] Department of Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
University of Miami · USSylvester Comprehensive Cancer Center · USUniversity of California, Davis · USLeiden University Medical Center · NL

Funding

Significance and Function of HGAL in LymphomaR01CA109335 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LOSSOS, IZIDORE S · 2005 to 2013
$2.1M
NCI NIH HHS CA109335
6 · The paper itself

Abstract

The pathogenesis of Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas (OAEMZLs) is poorly understood. OAEMZLs are monoclonal tumors expressing a biased repertoire of mutated surface immunoglobulins. Antigenic activation of the B-cell receptor (BCR) may have a role in the pathogenesis of these lymphomas. We have analyzed the reactivity of recombinant OAEMZL immunoglobulins. OAEMZL antibodies reacted with self-human antigens, as demonstrated by enzyme-linked immunosorbent assays, HEp-2 immunofluorescence and human protein microarrays. All the analyzed recombinant antibodies (rAbs) exhibited polyreactivity by comprehensive protein array antibody reactivity and some rAbs also demonstrated rheumatoid factor activity. The identity of several reactive antigens was confirmed by microcapillary reverse-phase high-performance liquid chromatography nano-electrospray tandem mass spectrometry. The tested rAbs frequently reacted with shared intracellular and extracellular self-antigens (for example, galectin-3). Furthermore, these self-antigens induced BCR signaling in B cells expressing cognate surface immunoglobulins derived from OAEMZLs. These findings indicate that interactions between self-antigens and cognate OAEMZL tumor-derived BCRs are functional, inducing intracellular signaling. Overall, our findings suggest that self-antigen-induced BCR stimulation may be implicated in the pathogenesis of C. psittaci-negative OAEMZLs.

Indexed as

Chlamydophila psittaciAutoantigensBlotting, WesternB-LymphocytesChromatography, High Pressure LiquidEnzyme-Linked Immunosorbent AssayEye NeoplasmsFluorescent Antibody TechniqueHumansImmunoenzyme TechniquesImmunoprecipitationLymphoma, B-Cell, Marginal ZoneProtein Array AnalysisPsittacosisReceptors, Antigen, B-CellRecombinant ProteinsAutoantigensReceptors, Antigen, B-CellRecombinant Proteins

Identifiers

PMID25676418
OpenAlexW1992202416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.